1.Zhu N, Chen M, Eng R, Sinha AU, Rahnamay NF, Koche R, Al-Shahrour F, Minehart JC, Chen CW, Deshpande AJ, Xu H, S. Chu H, Ebert BL, Roeder RG, Armstrong SA. Jmjd1c is required for MLL-AF9 and HOXA9 Mediated AML Stem Cell Self-Renewal. J. Clin. Invest. 2016 Mar 1;126(3):997-1011.
2.David CJ, Huang Y, Chen M, Su J, Zou Y, Bardeesy N, Iacobuzio-Donahue CA, Massagué J.TGF-β Tumor Suppression Through A Lethal EMT. Cell. 2016 Feb 25;164(5):1015-30.
3.Chen M, Zhu N, Liu X, Laurent B, Tang Z, Eng R, Shi Y, Armstrong SA, Roeder RG. JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors. Genes Dev. 2015 Oct 15;29(20):2123-39.
4.Chen M, David CJ, Manley JL (2012). Concentration-dependent control of pyruvate kinase M mutually exclusive splicing by hnRNP proteins. Nat Struct Mol Biol. 19(3):346-54.
5.Chen M, Zhang J, Manley JL (2010). Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA. Cancer Res. (22):8977-80Chen M, David CJ, Manley JL (2010).
6.Chen M, David CJ, Manley JL (2010). Tumor metabolism: hnRNP proteins get in on the act. Cell Cycle. 9: 1863-4.
7.David CJ#, Chen M#, Assanah M, Canoll P, Manley JL (2010) HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463: 364-8. #, These authors contributed equally to this work.
8.Chen M, Manley JL (2009). Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol. 10(11):741-54.
9.Feng Y, Chen M, Manley JL (2008). Phosphorylation switches the general splicing repressor SRp38 to a sequence-specific activator. Nat Struct Mol Biol. 15(10):1040-8.